WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today reported the commercial launch of DPNCheck in Mexico . The initial DPNCheck order will be utilized by one of Mexico's six major government healthcare institutions to improve the detection of diabetic neuropathy and advance the

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced that Shai N. Gozani , M.D., Ph.D., President and CEO, will participate in a panel titled "Roadmap to FDA Approval" on Tuesday, January 5 at the 2016 CES Event in Las Vegas . The panel moderator is Alfred Poor , Editor of

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell is available for purchase at FSAstore.com and HSAstore.com , the only e-commerce sites stocked exclusively with eligible products for Flexible Spending Account (FSA) and Health Savings Account (HSA)

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell has been selected as one of 10 finalists in the Last Gadget Standing event at CES 2016. Now in its 15th year, Last Gadget Standing is one of the best loved and longest running events at the International

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that it has expanded distribution of the Quell Wearable Pain Relief device to The Grommet, a unique online product launch platform. "The Quell technology immediately stood out as a unique innovation that would appeal to our

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) will unveil innovative enhancements to its Quell ® Wearable Pain Relief Technology™ at the 2016 CES Event January 6-9 in Las Vegas . CES is the largest consumer technology event and has served as the launch pad for innovators and

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today reported growing media coverage of the Company's innovative Quell ® Wearable Pain Relief Technology™. During the past two months, Quell has been featured on network television affiliates in New York , San Francisco , Philadelphia ,

Shares of Common Stock and Listed Warrants Have Begun Trading on a Split-Adjusted Basis on The NASDAQ Capital Market BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today confirmed that it has consummated a one-for-four reverse split of its common stock.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be participating in the Benchmark Micro Cap Discovery One-On-One Conference at the Palmer House Hilton in Chicago, IL on Thursday, December

Shares of Common Stock and Certain Warrants Will Begin Trading on a Split-Adjusted Basis on December 2, 2015 BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced a one-for-four reverse split of its common stock effective as of Tuesday, December 1, 2015 .